DEVELOPMENT OF A ‘NORMAL LIFE INDEX’ (NLI) FOR PATIENTS WITH IBD: ITEM SELECTION THROUGH A WORLD-WIDE PATIENT-CENTRED APPROACH

Joep van Oostrom  ¹     Suzanne Anjie  ¹     Marlou Braad  ¹     Jamie Horrigan  ²     Neda Karimi  ³     Bhargavi Adi  ⁴     Girish Ganesh  ⁴     Suk-Kyun Yang  ⁵     Juan Sebastian Lasa  ⁶     Christian Broër  ⁷     Anja de Kruif  ⁸     Pablo Olivera Sendra  ⁹     Byong Duk Ye  ⁹     Rupa Banerjee  ⁹     Susan J. Connor  ⁹     Corey A Siegel  ⁹     Laurent Peyrin-Biroulet  ¹⁰     Krisztina Barbara Gecse  ¹⁰     Geert R. D'Haens  ^10    
1 Amsterdam University Medical Center, Amsterdam, Netherlands
² Dartmouth Hitchcock Medical Center, Lebanon, United States
³ South West Sydney Clinical Campuses, UNSW Medicine and Health, Sydney, Australia
⁴ Asian Institute of Gastroenterology, Hyderabad, India
⁵ Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea (Republic of)
⁶ Centro de Educación Médica e Investigación Clínica (CEMIC), Ciudad Autonoma Buenos Aires, Argentina
⁷ University of Amsterdam, Amsterdam, Netherlands
⁸ Free University, Amsterdam, Netherlands
⁹ Sinai Health System, Toronto, Canada
¹⁰ Nancy University Hospital, Vandoeuvre-les-Nancy, France

Session
Patient reported outcomes in IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)